---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-139899"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:39:17.600935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics raises ~$4.6M gross in registered direct offering of stock and prefunded warrants

## Summary
- Issued 405,000 shares at $6.25 each and prefunded warrants for 334,000 shares at $6.249 each.
- Net proceeds estimated at ~$4.1M after placement agent fees and expenses.
- Proceeds to support strategic alternative process and working capital; cash runway into Q2 2026.
- Placement agent H.C. Wainwright receives 6.0% cash fee on gross proceeds.
- Prefunded warrants exercisable at $0.001 per share, with 4.99% beneficial ownership limitation (holder may elect up to 9.99%).

## SEC filing metadata
- accession: 0001193125-25-139899
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/0001193125-25-139899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/d908664d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-139899
- JSON: https://secwatch.observer/filing/0001193125-25-139899.json
- Plain text: https://secwatch.observer/filing/0001193125-25-139899.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.